These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2296259)

  • 1. Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.
    Mitchell IJ; Luquin R; Boyce S; Clarke CE; Robertson RG; Sambrook MA; Crossman AR
    Mov Disord; 1990; 5(1):49-54. PubMed ID: 2296259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Mitchell IJ; Clarke CE; Boyce S; Robertson RG; Peggs D; Sambrook MA; Crossman AR
    Neuroscience; 1989; 32(1):213-26. PubMed ID: 2586750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]-2-deoxyglucose uptake study in mutant dystonic hamsters: abnormalities in discrete brain regions of the motor system.
    Richter A; Brotchie JM; Crossman AR; Löscher W
    Mov Disord; 1998 Jul; 13(4):718-25. PubMed ID: 9686781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: a 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease.
    Meissner W; Guigoni C; Cirilli L; Garret M; Bioulac BH; Gross CE; Bezard E; Benazzouz A
    Eur J Neurosci; 2007 Mar; 25(5):1492-500. PubMed ID: 17425575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural mechanisms mediating 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced parkinsonism in the monkey: relative contributions of the striatopallidal and striatonigral pathways as suggested by 2-deoxyglucose uptake.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    Neurosci Lett; 1986 Jan; 63(1):61-5. PubMed ID: 3485267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia.
    Mitchell IJ; Boyce S; Sambrook MA; Crossman AR
    Brain; 1992 Jun; 115 ( Pt 3)():809-24. PubMed ID: 1628204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey.
    Crossman AR; Mitchell IJ; Sambrook MA
    Neuropharmacology; 1985 Jun; 24(6):587-91. PubMed ID: 3875056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of chorea and dystonia in parkinsonian primates.
    Boyce S; Clarke CE; Luquin R; Peggs D; Robertson RG; Mitchell IJ; Sambrook MA; Crossman AR
    Mov Disord; 1990; 5(1):3-7. PubMed ID: 2296255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey.
    Page RD; Sambrook MA; Crossman AR
    Neuroscience; 1993 Jul; 55(1):147-65. PubMed ID: 7688878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional (14C) 2-deoxyglucose uptake during vibrissae movements evoked by rat motor cortex stimulation.
    Sharp FR; Evans K
    J Comp Neurol; 1982 Jul; 208(3):255-87. PubMed ID: 7119161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey.
    Mitchell IJ; Crossman AR; Liminga U; Andren P; Gunne LM
    Mov Disord; 1992; 7(1):32-7. PubMed ID: 1557064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
    Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G
    Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional changes in brain 2-14C-deoxyglucose uptake induced by convulsant and non-convulsant doses of lindane.
    Sanfeliu C; Solà C; Camón L; Martínez E; Rodríguez-Farré E
    Neurotoxicology; 1989; 10(4):727-42. PubMed ID: 2483996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate.
    Aziz TZ; Peggs D; Sambrook MA; Crossman AR
    Mov Disord; 1991; 6(4):288-92. PubMed ID: 1758446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the monkey: neurochemical pathology and regional brain metabolism.
    Mitchell IJ; Cross AJ; Sambrook MA; Crossman AR
    J Neural Transm Suppl; 1986; 20():41-6. PubMed ID: 3462325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys.
    Akai T; Yamaguchi M; Mizuta E; Kuno S
    Ann Neurol; 1993 May; 33(5):507-11. PubMed ID: 8098931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
    Synapse; 2006 Sep; 60(3):239-50. PubMed ID: 16739115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifications of local cerebral glucose utilization in thalamic structures following injection of a dopaminergic agonist in the nucleus accumbens--involvement in antiepileptic effects?
    Riban V; Pereira de Vasconcelos A; Phâm-Lê BT; Ferrandon A; Marescaux C; Nehlig A; Depaulis A
    Exp Neurol; 2004 Aug; 188(2):452-60. PubMed ID: 15246844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.